Biomedical Informatics Core

生物医学信息学核心

基本信息

  • 批准号:
    10201622
  • 负责人:
  • 金额:
    $ 32.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-15 至 2022-08-04
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY: BIOMEDICAL INFORMATICS (BMI) CORE The mission of the Biomedical Informatics (BMI) Key Component Activity (KCA) of the Louisiana Clinical and Translational Science Center (LA CaTS) is to develop and deploy “state of the art” biomedical informatics capabilities and services across all partner institutions, in support of clinical and translational research aimed at improving health outcomes and addressing disparities in our most vulnerable populations. Over the past 4 years, the BMI KCA supported 55 LA CaTS Investigators across 14 institutions, resulting in 27 publications and 7 funded grant applications. During the next funding period, the BMI KCA will pursue several innovative goals: 1) the creation of i2b2-searchable “virtual cohorts” for diseases disproportionately affecting Louisiana patients; 2) the participation in the Southeast SHRINE and TriNetX clinical data networks; 3) the integration of genomic, pathologic and clinical datasets; and 4) the creation of a searchable “virtual biorepository” linking physical biorepositories across LA CaTS institutions. We will leverage key collaborations with: PCORI-funded REACHnet; UAB- and Medical University of South Carolina (MUSC)-led CTSA Centers; the Precision Medicine and Bioinformatics Programs at LSUHSC-New Orleans, and the Louisiana Tumor Registry (LTR). We are excited about expanding our services to our LA CaTS new partner institutions: the LSUHSC Dental and Nursing Schools, the Southeast Louisiana Veterans Healthcare System, the University Medical Center in New Orleans and Ochsner Health System. To accomplish our mission, we propose the following aims: Specific Aim 1. To significantly expand ongoing BMI services and to build on our experience to develop novel analytical tools for data mining, precision medicine and molecular epidemiology. Specific Aim 2. To expand our ability to enable meaningful collaboration and data sharing between LA CaTS Investigators and Louisiana-based Louisiana Biomedical Research Network (LBRN) and Centers of Biomedical Research Excellence (COBRE) Centers, and between LA CaTS Investigators and CTSA Centers regionally and nationally, and to increase cyber access to underserved populations. Specific Aim 3. To provide continued, coordinated support for project design and implementation and professional development, in close cooperation with the Clinical Research Resources (CRR), Design, Epidemiology and Biostatistics (DEB), Cyberinfrastructure Enhancement (CE), Professional Development (PD), Ethics and Regulatory Knowledge (ERKC) and Health Literacy (HL) KCAs.
项目总结:生物医学信息学(BMI)核心 路易斯安那州临床和医学中心生物医学信息学(BMI)关键组成活动(KCA)的使命 转化科学中心(LA CaTS)是开发和部署“最先进的”生物医学信息学 所有合作机构的能力和服务,以支持临床和转化研究, 改善卫生成果,解决我们最弱势群体的差距。在过去4 年,BMI KCA支持了14家机构的55名LA CaTS研究者,发表了27篇出版物, 7资助申请在下一个资助期间,BMI KCA将追求几个创新目标: 1)创建i2 b2可搜索的“虚拟队列”,用于不成比例地影响路易斯安那州患者的疾病; 2)参与东南SHRINE和TriNetX临床数据网络; 3)整合基因组, 病理和临床数据集;以及4)创建一个可搜索的“虚拟生物库”, 在洛杉矶CaTS机构的生物储存库。我们将利用与以下机构的关键合作: REACHnet; UAB-和南卡罗来纳州医科大学(MUSC)领导的CTSA中心;精准医学 和生物信息学项目,以及路易斯安那州肿瘤登记处(LTR)。我们 很高兴将我们的服务扩展到我们的LA CaTS新合作伙伴机构:LSUHSC牙科和 护理学校,路易斯安那州东南部退伍军人医疗保健系统,新的大学医疗中心 奥尔良和奥克斯纳卫生系统。为了完成我们的使命,我们提出以下目标: 具体目标1.显著扩大BMI的现有服务,并在我们的经验基础上开发新的 用于数据挖掘、精准医学和分子流行病学的分析工具。 具体目标2。为了扩大我们的能力,使有意义的合作和数据共享之间的洛杉矶CaTS 研究人员和路易斯安那州的路易斯安那州生物医学研究网络(LBRN)和生物医学中心 卓越研究(COBRE)中心以及LA CaTS研究者与CTSA区域中心之间的合作 在全国范围内,并增加对服务不足人群的网络访问。 具体目标3。为项目设计和执行提供持续、协调的支助, 专业发展,与临床研究资源(CRR),设计, 流行病学和生物统计学(DEB),网络基础设施增强(CE),专业发展 (PD)伦理和监管知识(ERKC)和健康素养(HL)KCA。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lucio Miele其他文献

Lucio Miele的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lucio Miele', 18)}}的其他基金

Understanding and Addressing Cancer Health Disparities in Louisiana
了解并解决路易斯安那州的癌症健康差异
  • 批准号:
    9894562
  • 财政年份:
    2019
  • 资助金额:
    $ 32.51万
  • 项目类别:
Understanding and Addressing Cancer Health Disparities in Louisiana
了解并解决路易斯安那州的癌症健康差异
  • 批准号:
    9630120
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
Understanding and Addressing Cancer Health Disparities in Louisiana
了解并解决路易斯安那州的癌症健康差异
  • 批准号:
    10005206
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
Project 1-Immunogenomic diversity in triple negative breast cancer health disparities
项目 1-三阴性乳腺癌健康差异中的免疫基因组多样性
  • 批准号:
    10005253
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
Understanding and Addressing Cancer Health Disparities in Louisiana
了解并解决路易斯安那州的癌症健康差异
  • 批准号:
    9788353
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
2/2 东南部改善研究伙伴关系
  • 批准号:
    10005326
  • 财政年份:
    2017
  • 资助金额:
    $ 32.51万
  • 项目类别:
Targeting y-secretase in breast cancer
靶向乳腺癌中的γ分泌酶
  • 批准号:
    8415151
  • 财政年份:
    2013
  • 资助金额:
    $ 32.51万
  • 项目类别:
Core 06: Biomedical Informatics Core
核心06:生物医学信息学核心
  • 批准号:
    10677712
  • 财政年份:
    2012
  • 资助金额:
    $ 32.51万
  • 项目类别:
Core 06: Biomedical Informatics Core
核心06:生物医学信息学核心
  • 批准号:
    10667109
  • 财政年份:
    2012
  • 资助金额:
    $ 32.51万
  • 项目类别:
ANTI-NEOPLASTIC EFFECTS OF GAMMA-SECRETASE INHIBITORS
γ-分泌酶抑制剂的抗肿瘤作用
  • 批准号:
    7060670
  • 财政年份:
    2005
  • 资助金额:
    $ 32.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了